Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial

A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a protein that enables cancer cells to multiply and spread, was well tolerated and helped to stabilize the disease, helping to preserve the patients’ quality of life.

Read more: https://www.genengnews.com/topics/cancer/brain-cancer-therapy-shows-promise-in-pediatric-clinical-trial/